基本信息
浏览量:174
职业迁徙
个人简介
Our aims are to utilise molecular biology to establish new technologies to study and understand cancer. We are trying to define how chromosomal translocation genes affect proliferation and differentiation from cancer initiating cells (where translocations occur) to overt cancer and in epithelial cancers, to invasive disease. This work amalgamates technologies for creating in vivo models of chromosomal translocations that mark the cancer initiating cells with fluorescent protein expression and transcriptome analysis (concentrating on the surfaceome and transcription factor expression patterns) using deep sequencing RNA-seq to discover new potential therapy targets.
The second, allied aim of our work, involves establishing technologies to target protein function inside cells particularly protein-protein interactions, using antibody fragments as drug surrogates for functional ablation of target proteins (our intracellular immunotherapy programme). We are isolating small molecules and peptides that mirror the inhibitory properties of the antibody fragments and our goals are to develop laboratory reagents to study cancer development and drug-like molecules as leads for therapeutic application. Allied to these approaches, we are examining cell surface protein expression in primary tumours and metastatic disease to define cell interactions that potentiate cancer and identify molecules at the cell surface that could be used in therapy, such as conventional antibody-mediated cancer treatment.
The second, allied aim of our work, involves establishing technologies to target protein function inside cells particularly protein-protein interactions, using antibody fragments as drug surrogates for functional ablation of target proteins (our intracellular immunotherapy programme). We are isolating small molecules and peptides that mirror the inhibitory properties of the antibody fragments and our goals are to develop laboratory reagents to study cancer development and drug-like molecules as leads for therapeutic application. Allied to these approaches, we are examining cell surface protein expression in primary tumours and metastatic disease to define cell interactions that potentiate cancer and identify molecules at the cell surface that could be used in therapy, such as conventional antibody-mediated cancer treatment.
研究兴趣
论文共 327 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Daniel J.L. Coleman,Peter Keane,Paulynn S. Chin,Luke Ames,Sophie Kellaway,Helen Blair,Naeem Khan,James Griffin, Elizabeth Holmes, Alexander Maytum,Sandeep Potluri, Lara Strate,
iScienceno. 4 (2024): 109576-109576
ANTIBODIESno. 1 (2023): 24-24
Cristiana Barone, Roberto Orsenigo, Anna Cazzola, Elisabetta D'Errico, Arianna Patelli, Giulia Quattrini, Barbara Vergani, Silvia Bombelli, Sofia De Marco, Cristina D'Orlando,Cristina Bianchi,Biagio Eugenio Leone,
CANCERSno. 14 (2023)
CURRENT OPINION IN BIOMEDICAL ENGINEERING (2023): 100455-100455
引用0浏览0引用
0
0
Science Advancesno. 45 (2022): eabm3548-eabm3548
Jing Zhang,Arvind Jain,Sabine Milhas, Daniel J Williamson, Justyna Mysliwy,Adam Lodge,Jenny Thirlway, Majid Al Nakeeb,Ami Miller,Terry H Rabbitts
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn